YAP promotes ocular neovascularization by modifying PFKFB3-driven endothelial glycolysis
- 5 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Angiogenesis
- Vol. 24 (3), 489-504
- https://doi.org/10.1007/s10456-020-09760-8
Abstract
Ocular neovascularization is the leading cause of vision impairment in a variety of ocular diseases, such as age-related macular degeneration and retinopathy of prematurity. Emerging studies have suggested that the yes-associated protein (YAP), a downstream effector of the Hippo pathway, is involved in the pathological angiogenesis, but the mechanism are largely unknown. Here, we demonstrated that hypoxic treatment triggered YAP expression and nuclear translocation in human umbilical vein endothelial cells (HUVECs). YAP acted as a transcriptional co-activator working together with transcriptional enhancer activator domain 1 (TEAD1) to binds the promoter of the key glycolytic regulator 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase3 (PFKFB3), and thereby increases PFKFB3 expression. Moreover, silencing of YAP inhibited glycolysis as well as proliferation, migration, sprouting and tube formation of HUVECs under hypoxia, all of which could be reversed by enforced expression of PFKFB3. Finally, our animal study also showed that intravitreal injection of small interfering RNA of YAP or PFKFB3 dramatically suppressed the neovascular growth in mouse models of choroidal neovascularization and oxygen-induced retinopathy. These findings provide new insights into a previously unrecognized effect of YAP on endothelial glycolysis and highlight the potential of targeting YAP/PFKFB3 axis in the treatment of ocular neovascularization.Keywords
Funding Information
- National Nature Science Foundation of China (81970817, 81873680, 81800843, 81600735)
- Excellent Youth Talent Program of Zhongshan Hospital (2017ZSYXQN30)
This publication has 57 references indexed in Scilit:
- Use of the mouse aortic ring assay to study angiogenesisNature Protocols, 2011
- Molecular mechanisms and clinical applications of angiogenesisNature, 2011
- Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesisNature Protocols, 2009
- Vascular endothelial growth factor in eye diseaseProgress in Retinal and Eye Research, 2008
- Fasudil-induced hypoxia-inducible factor-1α degradation disrupts a hypoxia-driven vascular endothelial growth factor autocrine mechanism in endothelial cellsMolecular Cancer Therapeutics, 2008
- Retinal and choroidal microangiopathies: Therapeutic opportunitiesMicrovascular Research, 2007
- Anti-vascular endothelial growth factor therapy for ocular neovascular diseaseCurrent Opinion in Opthalmology, 2007
- Aerobically Derived Lactate Stimulates Revascularization and Tissue Repair via Redox MechanismsAntioxidants and Redox Signaling, 2007
- The Hippo Signaling Pathway Coordinately Regulates Cell Proliferation and Apoptosis by Inactivating Yorkie, the Drosophila Homolog of YAPCell, 2005
- Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAsNature, 2004